Is this you? Create Your Porfile
Avatar

Buettner Frank

Aventis Pharma

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Buettner Frank is active.

Explore More

Publication

Featured researches published by Buettner Frank.

Archive | 1998

New sulfonylamino-phosphinic or phosphonic acids, used as matrix metalloproteinase inhibitors for treating e.g. degenerative joint diseases, atherosclerosis, inflammation or cancer

Schudok Manfred; Schwab Wilfried; Zoller Gerhard; Bartnik Eckart; Buettner Frank; Weithmann Klaus-Ulrich

Archive | 2003

Phosphin- og phosphonsyrederivater som lægemidler

Schudok Manfred; Zoller Gerhard; Bartnik Eckart; Buettner Frank; Weithmann Klaus-Ulrich; Schwab Wilfried

Archive | 2001

PHOSPHINOUS AND PHOSPHONIC ACID DERIVATIVES, THEIR USE MEDICAMENTS CONTAINING THE SAME AND PROCESS FOR PRODUCING THEM

Bartnik Eckart; Buettner Frank; Schudok Manfred; Schwab Wilfried; Weithmann Klaus-Ulrich; Zoller Gerhard

Archive | 2001

Derivatives of phosphinic and phosphonic acids, process of their preparation and medicament in which they are comprised

Schudok Manfred; Schwab Wilfried; Zoller Gerhard; Bartnik Eckart; Buettner Frank; Weithmann Klaus-Ulrich

Archive | 2001

Ilaç olarak fosfin-ve fosfon asit türevleri

Schudok Manfred; Schwab Wilfried; Zoller Gerhard; Bartnik Eckart; Buettner Frank; Weithmann Klaus-Ulrich

Archive | 2001

SUBSTRATO RECOMBINANTE ARTIFICIAL (RAGG 1) E AGRECANO NATIVO PARA ESTUDAR A ACTIVIDADE PROTEOLITICA DE `AGRECANASE´ EM SISTEMAS DE CULTURA DE CELULAS

Bartnik Eckart; Eidenmueller Bernd; Buettner Frank; Caterson Bruce; Hughes Clare

Archive | 2001

Derivados de ácido fosfìnico e ácido fosfÈnico como medicamentos

Schudok Manfred; Schwab Wilfried; Zoller Gerhard; Bartnik Eckart; Buettner Frank; Weithmann Klaus-Ulrich

Archive | 2000

UN SUSTRATO RECOMBINANTE ARTIFICIAL (RAGG-1) Y AGRECANO NATIVO PARA ESTUDIAR LA ACTIVIDAD PROTEOLITICA DE LA "AGRECANASA" EN SISTEMAS DE CULTIVO CELULAR.

Bartnik Eckart; Eidenmueller Bernd; Buettner Frank; Caterson Bruce; Hughes Clare

Archive | 2000

Kunstigt rekombinant substrat (rAGG-1) og nativ aggrecan til undersøgelse af den proteolytiske aktivitet af "aggrecanase" i

Bartnik Eckart; Eidenmueller Bernd; Buettner Frank; Caterson Bruce; Hughes Clare

Archive | 2000

New sulfonylamino- or carbonylamino-phosphinic or phosphonic acids, used as matrix metalloproteinase inhibitors for treating, e.g. degenerative joint diseases

Schudok Manfred; Schwab Wilfried; Zoller Gerhard; Bartnik Eckart; Buettner Frank; Weithmann Klaus-Ulrich

Explore More

Collaboration

Dive into the Buettner Frank's collaboration.

Top Co-Authors
Avatar

Bartnik Eckart

Aventis Pharma

View shared research outputs
Top Co-Authors
Avatar

Schudok Manfred

Aventis Pharma

View shared research outputs
Top Co-Authors
Avatar

Schwab Wilfried

Aventis Pharma

View shared research outputs
Top Co-Authors
Avatar

Weithmann Klaus-Ulrich

Aventis Pharma

View shared research outputs
Top Co-Authors
Avatar

Zoller Gerhard

Aventis Pharma

View shared research outputs
Explore More
Researchain Logo
Decentralizing Knowledge